Added to YB: 2025-01-20
Pitch date: 2025-01-19
CLPT [bullish]
ClearPoint Neuro, Inc.
-26.87%
current return
Author Info
No bio for this author
Company Info
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States.
Market Cap
$365.6M
Pitch Price
$16.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
-17.88
P/E
-12.07
EV/Sales
9.69
Sector
Health Care Equipment and Supplies
Category
growth
ClearPoint Neuro, Inc. - $CLPT
CLPT: FDA approval of Upstaza gene therapy delivery using ClearPoint system is game-changer. Pharma partners now drive hospital adoption. 50+ advanced hospital conversations, 100+ total. New products in 2024-2025 boost usage. Q2'23 call outlines decade strategy: pricing power, monopoly, regulatory capture. Possible $10-15M raise for breakeven.
Read full article (3 min)